These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35215805)

  • 1. The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19.
    Babkina AS; Ostrova IV; Yadgarov MY; Kuzovlev AN; Grechko AV; Volkov AV; Golubev AM
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
    Philippe A; Chocron R; Gendron N; Bory O; Beauvais A; Peron N; Khider L; Guerin CL; Goudot G; Levasseur F; Peronino C; Duchemin J; Brichet J; Sourdeau E; Desvard F; Bertil S; Pene F; Cheurfa C; Szwebel TA; Planquette B; Rivet N; Jourdi G; Hauw-Berlemont C; Hermann B; Gaussem P; Mirault T; Terrier B; Sanchez O; Diehl JL; Fontenay M; Smadja DM
    Angiogenesis; 2021 Aug; 24(3):505-517. PubMed ID: 33449299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.
    Ward SE; Curley GF; Lavin M; Fogarty H; Karampini E; McEvoy NL; Clarke J; Boylan M; Alalqam R; Worrall AP; Kelly C; de Barra E; Glavey S; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Townsend L; Mallon PW; O'Sullivan JM; O'Donnell JS;
    Br J Haematol; 2021 Feb; 192(4):714-719. PubMed ID: 33326604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy.
    Mei ZW; van Wijk XMR; Pham HP; Marin MJ
    J Appl Lab Med; 2021 Sep; 6(5):1305-1315. PubMed ID: 33930144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
    Ladikou EE; Sivaloganathan H; Milne KM; Arter WE; Ramasamy R; Saad R; Stoneham SM; Philips B; Eziefula AC; Chevassut T
    Clin Med (Lond); 2020 Sep; 20(5):e178-e182. PubMed ID: 32694169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19.
    Flores-Pliego A; Miranda J; Vega-Torreblanca S; Valdespino-Vázquez Y; Helguera-Repetto C; Espejel-Nuñez A; Borboa-Olivares H; Espino Y Sosa S; Mateu-Rogell P; León-Juárez M; Ramírez-Santes V; Cardona-Pérez A; Villegas-Mota I; Torres-Torres J; Juárez-Reyes Á; Rizo-Pica T; González RO; González-Mariscal L; Estrada-Gutierrez G
    Cells; 2021 Feb; 10(2):. PubMed ID: 33578631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of von Willebrand factor in capillary endothelial cells of rat lungs with pulmonary fibrosis.
    Kasper M; Schöbl R; Haroske G; Fischer R; Neubert F; Dimmer V; Müller M
    Exp Toxicol Pathol; 1996 Jun; 48(4):283-8. PubMed ID: 8811296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.
    Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
    Manz XD; Szulcek R; Pan X; Symersky P; Dickhoff C; Majolée J; Kremer V; Michielon E; Jordanova ES; Radonic T; Bijnsdorp IV; Piersma SR; Pham TV; Jimenez CR; Vonk Noordegraaf A; de Man FS; Boon RA; Voorberg J; Hordijk PL; Aman J; Bogaard HJ
    Am J Respir Crit Care Med; 2022 Apr; 205(7):806-818. PubMed ID: 35081007
    [No Abstract]   [Full Text] [Related]  

  • 11. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.
    Sabharwal AK; Bajaj SP; Ameri A; Tricomi SM; Hyers TM; Dahms TE; Taylor FB; Bajaj MS
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):758-67. PubMed ID: 7881667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs.
    Brouland JP; Egan T; Roussi J; Bonneau M; Pignaud G; Bal C; Vaiman M; André P; Hervé P; Mazmanian GM; Drouet L
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):3055-62. PubMed ID: 10591687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19.
    Choudhary S; Sharma K; Singh PK
    Chem Biol Interact; 2021 Oct; 348():109657. PubMed ID: 34516971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity.
    Michels A; Dwyer CN; Mewburn J; Nesbitt K; Kawecki C; Lenting P; Swystun LL; Lillicrap D
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2860-2874. PubMed ID: 32967458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Von Willebrand factor and pulmonary endothelial dysfunction. Prognostic implications].
    Lopes AA; Maeda NY; Bydlowski SP
    Arq Bras Cardiol; 1998 Mar; 70(3):141-5. PubMed ID: 9674173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk.
    Langholm LL; Rønnow SR; Sand JMB; Leeming DJ; Tal-Singer R; Miller BE; Vestbo J; Karsdal MA; Manon-Jensen T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():543-552. PubMed ID: 32210548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage.
    Fukuchi M; Watanabe J; Kumagai K; Katori Y; Baba S; Fukuda K; Yagi T; Iguchi A; Yokoyama H; Miura M; Kagaya Y; Sato S; Tabayashi K; Shirato K
    J Am Coll Cardiol; 2001 Apr; 37(5):1436-42. PubMed ID: 11300458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
    Schultze AE; Emeis JJ; Roth RA
    Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension.
    Lopes AA; Maeda NY; Aiello VD; Ebaid M; Bydlowski SP
    Chest; 1993 Nov; 104(5):1455-60. PubMed ID: 8222806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.